*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>4-(Piperidin-4-yl)morpholine 2,2,2-trifluoroacetate</strong> is a pharmaceutical intermediate salt form synthesized via alkylation of piperidine with morpholine followed by trifluoroacetylation. Its molecular formula is C<sub>9</sub>H<sub>17</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>. This compound serves as a critical building block in the manufacturing of complex heterocyclic APIs.</p>
<h3>Application</h3>
<ul>
<li><strong>Medicinal Chemistry:</strong> Used as a scaffold for developing CNS-active compounds and GPCR modulators.</li>
<li><strong>Process Development:</strong> Employed in solid-phase synthesis and library generation for high-throughput screening.</li>
<li><strong>Pharmaceutical Manufacturing:</strong> Intermediate for synthesizing specific antidepressant and analgesic agents.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at 2-8°C to prevent hydrolysis. Handle with appropriate PPE due to potential respiratory sensitization. Do not use in unapproved clinical trials without rigorous toxicological validation.</p>